These authors noted that in an SLE cohort there were no clinical differences between the few patients with anti-DFS70/LEDGFp75 antibodies and the patients without these antibodies, suggesting that the antibodies are not protective and do not correlate with disease activity. Here, PSIP1 is linked to systemic lupus erythematosus.